We invite you to join us for the 2nd AAT-AD/PD™ Focus Meeting 2020, for the first time an entirely virtual meeting.. The first AAT-AD/PD™ Focus Meeting 2018 was held in Torino, Italy with 1337 participants.
The Meeting will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PD™ 2019, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Join us online on 2-5 April 2020.
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!